Just when you thought Apple was working on a bigger iPad and iPhone, its top executives met with the U.S. Food and Drug Administration to discuss on “mobile medical applications.” The story was also covered last week in the Friday edition of the New York Times. Much of the speculations are around developing applications for the iWatch, which is expected to be launched by end of this year.
The meeting included top of the line executives from Apple including Senior Vice President of Operations Jeff Williams, Vice President of Software Technology Bud Tribble and Michael O’Reilly (who recently joined Apple from the medical monitoring company Masimo). From thr FDA’s panel, Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, and Bakul Patel, who helped draft the FDA’s guidance on mobile medical applications, had attended the meeting, reports Times. [@HealthITplus]
Apples’ smart watch, purportedly iWatch, has been reported to include apps and run on Apple’s native iOS mobile operating system. The iWatch will also be able to capture physiological data and synch wirelessly with a smartphone, according to Times.
“Given the amount of work going on inside Apple, and the meetings with high-level government officials, it’s possible that Apple could be working on other gadgets beyond the smartwatch that focus on healthcare, which is a $1.6 trillion industry, according to the United States Census Bureau estimate,” the Times reported.
This isn’t the first time healthcare entrepreneurs have tried to fit mHealth technology into a watch, and it remains to be seen whether the technology has advanced far enough that companies like Apple can overcome issues with sensor reliability and battery life.
Like this story? Share and subscribe to HealthIT+ monthly newsletter